Skip to main content

Table 2 Inhibition of L. donovani L GSK-3 and L. mexicana L CRK3 by compounds 11–17

From: An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3

 

IC50(μM)

Compounds

L GSK-3

L CRK3

6-BIO

0.15 ± 0.06

0.02 ± 0.01

5-Me-6-BIO

0.09 ± 0.02

0.65 ± 0.09

11

0.10 ± 0.07

>3.33

12

0.20 ± 0.08

0.99 ± 0.19

13

1.65 ± 0.17

>3.33

14

1.95 ± 0.11

>3.33

15

0.17 ± 0.25

0.14 ± 0.06

16

0.36 ± 0.18

>3.33

17

0.88 ± 0.26

>3.33

  1. Inhibitory kinase activity of the controls 6BIO and 5-Me-6-BIO is also shown. IC50 values are expressed in μΜ.